| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
5,607 |
5,142 |
$654K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,239 |
3,900 |
$509K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,157 |
10,706 |
$488K |
| 81025 |
|
5,683 |
5,434 |
$452K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,557 |
3,120 |
$236K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,301 |
2,257 |
$223K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,308 |
2,266 |
$217K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,421 |
1,985 |
$155K |
| 81001 |
|
7,802 |
7,312 |
$143K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,096 |
3,767 |
$136K |
| 36415 |
Collection of venous blood by venipuncture |
1,014 |
864 |
$111K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,427 |
6,963 |
$106K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
517 |
506 |
$64K |
| 71046 |
Radiologic examination, chest; 2 views |
2,139 |
2,098 |
$56K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
754 |
735 |
$49K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,911 |
3,720 |
$44K |
| 87210 |
|
776 |
733 |
$41K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,534 |
1,496 |
$39K |
| 85027 |
|
1,265 |
1,150 |
$36K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
318 |
316 |
$33K |
| 84702 |
|
1,513 |
1,414 |
$32K |
| 70450 |
Computed tomography, head or brain; without contrast material |
604 |
591 |
$32K |
| 87081 |
|
234 |
234 |
$30K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
596 |
591 |
$26K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,133 |
1,109 |
$25K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,704 |
7,809 |
$25K |
| 71045 |
Radiologic examination, chest; single view |
1,722 |
1,669 |
$25K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
901 |
894 |
$21K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,759 |
3,408 |
$20K |
| 86900 |
|
260 |
251 |
$20K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
474 |
437 |
$18K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
166 |
161 |
$18K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
230 |
227 |
$16K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
81 |
81 |
$14K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,455 |
2,249 |
$14K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
165 |
165 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
73 |
73 |
$12K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
183 |
181 |
$11K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,003 |
1,935 |
$9K |
| 76642 |
|
305 |
255 |
$9K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
493 |
464 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,767 |
2,437 |
$7K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
238 |
209 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
303 |
301 |
$5K |
| 77066 |
Tomosynthesis, mammo |
43 |
43 |
$4K |
| J3490 |
Unclassified drugs |
1,233 |
867 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
15 |
15 |
$4K |
| 87077 |
|
158 |
156 |
$3K |
| 87428 |
|
43 |
42 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,245 |
1,059 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
428 |
422 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
89 |
88 |
$3K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
41 |
40 |
$2K |
| 84484 |
|
1,872 |
1,678 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,502 |
3,187 |
$2K |
| 81003 |
|
704 |
615 |
$2K |
| 76830 |
Ultrasound, transvaginal |
44 |
44 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,125 |
2,771 |
$1K |
| 72100 |
|
25 |
25 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
72 |
72 |
$1K |
| 99215 |
Prolong outpt/office vis |
30 |
25 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
418 |
407 |
$1K |
| 83690 |
|
2,730 |
2,548 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
287 |
285 |
$989.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,913 |
1,838 |
$970.23 |
| 85018 |
|
192 |
188 |
$897.07 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
111 |
101 |
$891.90 |
| 80061 |
Lipid panel |
187 |
187 |
$890.58 |
| 96376 |
|
132 |
107 |
$864.37 |
| 73630 |
|
13 |
13 |
$861.14 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
248 |
248 |
$853.93 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
428 |
416 |
$853.75 |
| 73130 |
|
13 |
13 |
$802.03 |
| 73560 |
|
27 |
26 |
$744.39 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
32 |
31 |
$715.39 |
| 86850 |
|
12 |
12 |
$694.85 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,938 |
1,864 |
$474.17 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
107 |
107 |
$459.83 |
| 76801 |
|
43 |
40 |
$392.40 |
| 73610 |
|
12 |
12 |
$261.46 |
| 83735 |
|
2,414 |
2,204 |
$216.67 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
270 |
268 |
$202.37 |
| 85379 |
|
198 |
196 |
$174.58 |
| 93976 |
|
492 |
460 |
$115.30 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
871 |
864 |
$112.44 |
| 86803 |
|
108 |
108 |
$105.78 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
26 |
24 |
$77.58 |
| 83880 |
|
16 |
14 |
$65.28 |
| 82570 |
|
64 |
60 |
$46.77 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
196 |
180 |
$42.53 |
| 83605 |
|
55 |
50 |
$27.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,997 |
2,826 |
$26.28 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,246 |
3,858 |
$21.85 |
| 82947 |
|
17 |
15 |
$20.96 |
| 86901 |
|
260 |
251 |
$16.05 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,444 |
1,386 |
$14.58 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
86 |
79 |
$12.91 |
| 86140 |
|
24 |
24 |
$11.17 |
| 85610 |
|
17 |
15 |
$2.57 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,083 |
825 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,752 |
1,717 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
281 |
259 |
$0.00 |
| 84703 |
|
24 |
24 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
71 |
58 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
13 |
13 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
78 |
77 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
59 |
41 |
$0.00 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
24 |
24 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
12 |
12 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
118 |
106 |
$0.00 |
| 80076 |
|
42 |
42 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
84 |
75 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
67 |
62 |
$0.00 |
| 94664 |
|
51 |
44 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
25 |
25 |
$0.00 |
| 87186 |
|
42 |
42 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
14 |
13 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
12 |
12 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
13 |
13 |
$0.00 |